Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.11% |
| 2 | Healthcare | 13.18% |
| 3 | Financials | 12.45% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Aqua Metals
AQMS
$9.78M
| $92K | ﹤0.01% |
153
| – | – |
|
|
EXK
4102
Endeavour Silver
EXK
$3.06B
| $92K | ﹤0.01% |
15,059
| – | – |
|
4103
Everspin Technologies
MRAM
$412M
| $92K | ﹤0.01% |
14,301
-2,198
| -13% | -$12.6K |
|
4104
Natural Health Trends
NHTC
$15.4M
| $92K | ﹤0.01% |
13,105
-1,471
| -10% | -$10.6K |
|
|
NINE
4105
DELISTED
Nine Energy Service
NINE
| $92K | ﹤0.01% |
31,185
-4,659
| -13% | -$10.6K |
|
4106
Westwater Resources
WWR
$75.7M
| $92K | ﹤0.01% |
19,347
-3,399
| -15% | -$15.3K |
|
|
DMK
4107
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $92K | ﹤0.01% |
+1,200
| New | +$73.1K |
|
|
HMPT
4108
DELISTED
Home Point Capital, Inc Common Stock
HMPT
| $92K | ﹤0.01% |
15,462
+909
| +6% | +$6.99K |
|
4109
Assembly Biosciences
ASMB
$587M
| $90K | ﹤0.01% |
1,916
-8,639
| -82% | -$428K |
|
|
SREV
4110
DELISTED
ServiceSource International, Inc.
SREV
| $90K | ﹤0.01% |
63,675
-234,562
| -79% | -$309K |
|
4111
Cabaletta Bio
CABA
$442M
| $89K | ﹤0.01% |
10,295
-40,435
| -80% | -$397K |
|
|
VRN
4112
DELISTED
Veren
VRN
| $88K | ﹤0.01% |
19,508
+1,699
| +10% | +$7.13K |
|
|
HEPA
4113
DELISTED
Hepion Pharmaceuticals
HEPA
| $87K | ﹤0.01% |
44
-5
| -10% | -$9.15K |
|
4114
Ring Energy
REI
$347M
| $87K | ﹤0.01% |
29,254
| – | – |
|
|
ENZ
4115
DELISTED
Enzo Biochem, Inc.
ENZ
| $87K | ﹤0.01% |
27,308
-127,303
| -82% | -$400K |
|
4116
Intellicheck
IDN
$75.9M
| $86K | ﹤0.01% |
10,217
-39,410
| -79% | -$323K |
|
|
AIOT
4117
PowerFleet Inc
AIOT
$421M
| $84K | ﹤0.01% |
11,601
-74,841
| -87% | -$546K |
|
|
MARK
4118
DELISTED
Remark Holdings, Inc.
MARK
| $84K | ﹤0.01% |
4,511
| – | – |
|
4119
Aprea Therapeutics
APRE
$8.2M
| $83K | ﹤0.01% |
842
-1,547
| -65% | -$143K |
|
4120
Pixelworks
PXLW
$46.3M
| $83K | ﹤0.01% |
2,032
-7,647
| -79% | -$300K |
|
4121
Eton Pharmaceutcials
ETON
$1.12B
| $82K | ﹤0.01% |
13,275
-32,112
| -71% | -$238K |
|
4122
AYTU BioPharma
AYTU
$24.8M
| $80K | ﹤0.01% |
796
-1,546
| -66% | -$181K |
|
4123
Perspective Therapeutics
CATX
$357M
| $80K | ﹤0.01% |
9,923
+7,443
| +300% | +$65.2K |
|
|
SNCR
4124
DELISTED
Synchronoss Technologies
SNCR
| $80K | ﹤0.01% |
2,478
-12,447
| -83% | -$350K |
|
|
QUMU
4125
DELISTED
Qumu Corp.
QUMU
| $79K | ﹤0.01% |
27,391
-1,704
| -6% | -$8.38K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.